Literature DB >> 27460073

Long-term quality of life, satisfaction, pelvic floor symptoms and regret after colpocleisis.

Alkisti Katsara1, Eduard Wight1, Viola Heinzelmann-Schwarz1, Tilemachos Kavvadias2.   

Abstract

PURPOSE: The aim of this study is to present long-term results including patients' satisfaction, pelvic floor symptoms, regret and change in body image in a long-term follow-up after colpocleisis.
METHODS: All women who underwent colpocleisis between September 2001 and February 2014 were identified from the hospital operating lists. These women were contacted for a telephone survey up to 13 years after surgery and asked to complete a structured questionnaire to assess patients' satisfaction, Quality of Life (QoL) and pelvic floor symptoms.
RESULTS: A total of 44 women underwent colpocleisis during the period from September 2001 to February 2014. Mean age was 78 years (range 65-91) years. Mean follow-up time was 41 months (range 10-120). Twenty women could be reached for the survey and were included in the analysis. 15 (75 %) reported a positive impact on QoL, 2 (10 %) a negative because of urinary problems, 2 (10 %) could not report any change in the QoL and 1 (5 %) could not answer this question. There was no recurrence of prolapse. The majority of patients (90 %) would undergo the same surgery again and no patient regretted the loss of her vaginal sexual function.
CONCLUSIONS: Colpocleisis seems to be an effective treatment for pelvic organ prolapse. In the long term, impact on quality of life is positive, whilst urinary tract symptoms seem to be the most bothersome factor.

Entities:  

Keywords:  Colpocleisis; Long-term follow-up; Pelvic organ prolapse

Mesh:

Year:  2016        PMID: 27460073     DOI: 10.1007/s00404-016-4158-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  Pelvic organ prolapse: Considerations in surgical management: NYU Case of the Month, April 2017.

Authors:  Nirit Rosenblum
Journal:  Rev Urol       Date:  2017

Review 2.  Enlightening the mechanisms of POP recurrence after LeFort colpocleisis. Case report and review.

Authors:  Themistoklis Mikos; Mariliz Chatzipanteli; Grigoris F Grimbizis; Basil C Tarlatzis
Journal:  Int Urogynecol J       Date:  2016-12-26       Impact factor: 2.894

Review 3.  Role of Hysteropexy in the Management of Pelvic Organ Prolapse.

Authors:  Zoe S Gan; Daniel S Roberson; Ariana L Smith
Journal:  Curr Urol Rep       Date:  2022-07-05       Impact factor: 2.862

Review 4.  How does colpocleisis for pelvic organ prolapse in older women affect quality of life, body image, and sexuality? A critical review of the literature.

Authors:  Laetitia Felder; Viola Heinzelmann-Schwarz; Tilemachos Kavvadias
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

Review 5.  Colpocleisis as an obliterative surgery for pelvic organ prolapse: is it still a viable option in the twenty-first century? Narrative review.

Authors:  Magdalena Emilia Grzybowska; Konrad Futyma; Aida Kusiak; Dariusz Grzegorz Wydra
Journal:  Int Urogynecol J       Date:  2021-08-18       Impact factor: 1.932

6.  Razor-type dermatomes enable quick and thin vaginal dissection with less bleeding in colpocleisis.

Authors:  Kumiko Kato; Yuji Hayashi; Mami Adachi; Ryota Ando; Hideji Kawanishi; Hirotaka Matsui; Takashi Kato; Hiroki Hirabayashi; Shoji Suzuki; Ryohei Hattori
Journal:  Int Urogynecol J       Date:  2019-11-27       Impact factor: 2.894

7.  Impact of surgery on quality of life of Ugandan women with symptomatic pelvic organ prolapse: a prospective cohort study.

Authors:  Musa Kayondo; Dan Kabonge Kaye; Richard Migisha; Rodgers Tugume; Paul Kalyebara Kato; Henry Mark Lugobe; Verena Geissbüehler
Journal:  BMC Womens Health       Date:  2021-06-25       Impact factor: 2.809

8.  Long-Term Clinical Outcomes, Recurrence, Satisfaction, and Regret After Total Colpocleisis With Concomitant Vaginal Hysterectomy: A Retrospective Single-Center Study.

Authors:  Meiqiu Lu; Wei Zeng; Rui Ju; Shasha Li; Xin Yang
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-04-01       Impact factor: 1.913

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.